Aspira Women's Health (AWH) Stock Price, News & Analysis

Company Overview

Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.

Key Stats

• Today's Range: $0.08 to $0.09
• 50-Day Range: $0.08 to $0.23
• 52-Week Range: $0.08 to $3.28
• Volume: 4.31 million shs
• Average Volume: 1.28 million shs
• Market Capitalization: $2.44 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $5.50
• Consensus Rating: Buy

Aspira Women's Health Stock Analysis - MarketRank™

Aspira Women's Health scored higher than 34% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Aspira Women's Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Aspira Women's Health has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Aspira Women's Health is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Aspira Women's Health is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.19% of the float of Aspira Women's Health has been sold short.

Short Interest Ratio / Days to Cover

Aspira Women's Health has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Aspira Women's Health has recently decreased by 73.98%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: Weak

Dividend Yield

Aspira Women's Health does not currently pay a dividend.

Dividend Growth

Aspira Women's Health does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.19% of the float of Aspira Women's Health has been sold short.

Short Interest Ratio / Days to Cover

Aspira Women's Health has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Aspira Women's Health has recently decreased by 73.98%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

MarketBeat Follows

Only 1 people have added Aspira Women's Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Aspira Women's Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 4.30% of the stock of Aspira Women's Health is held by insiders.

Percentage Held by Institutions

Only 12.19% of the stock of Aspira Women's Health is held by institutions.

AWH Stock Analysis - Frequently Asked Questions

How have AWH shares performed this year?

Aspira Women's Health's stock was trading at $0.7050 on January 1st, 2025. Since then, AWH shares have decreased by 88.4% and is now trading at $0.0820.
View the best growth stocks for 2025 here.

How were Aspira Women's Health's earnings last quarter?

Aspira Women's Health Inc. (NASDAQ:AWH) issued its earnings results on Thursday, March, 27th. The company reported ($0.08) earnings per share for the quarter, beating analysts' consensus estimates of ($0.21) by $0.13. The business had revenue of $2.35 million for the quarter, compared to analysts' expectations of $3 million.

When did Aspira Women's Health's stock split?

Aspira Women's Health's stock reverse split on Friday, May 12th 2023. The 1-15 reverse split was announced on Friday, May 12th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 12th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

How do I buy shares of Aspira Women's Health?

Shares of AWH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Aspira Women's Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Aspira Women's Health investors own include Tesla (TSLA), Moderna (MRNA), Plug Power (PLUG), Riot Platforms (RIOT), Himax Technologies (HIMX) and HIVE Digital Technologies (HIVE).

Company Calendar

• Last Earnings: 3/27/2025
• Today: 5/03/2025
• Next Earnings (Estimated): 5/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Diagnostic substances
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:AWH
• CIK: 926617
• Web: www.aspirawh.com
• Phone: 512-519-0400
• Fax: 512-439-6908
• Employees: 110
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $5.50
• High Stock Price Target: $5.50
• Low Stock Price Target: $5.50
• Potential Upside/Downside: +6,607.3%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.98)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-16,690,000.00
• Net Margins: -165.07%
• Pretax Margin: -165.07%
• Return on Equity: N/A
• Return on Assets: -267.23%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.75
• Quick Ratio: 0.70

Sales & Book Value

• Annual Sales: $9.18 million
• Price / Sales: 0.27
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.23) per share
• Price / Book: -0.36

Miscellaneous

• Outstanding Shares: 29,764,000
• Free Float: 16,915,000
• Market Cap: $2.44 million
• Optionable: No Data
• Beta: 2.01